AQR Capital Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.55M | Buy |
|
|||||
|
2025
Q1 | $340K | Buy |
|
|||||
|
2024
Q4 | $297K | Buy |
|
|||||
|
2024
Q3 | $186K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $304K | Buy |
|
|||||
|
2022
Q1 | $132K | Buy |
|
|||||
|
2021
Q4 | $185K | Buy |
|
|||||
|
2021
Q3 | $210K | Buy |
|
|||||
|
2021
Q2 | $53K | Sell |
|
|||||
|
2021
Q1 | $133K | Sell |
|
|||||
|
2020
Q4 | $560K | Sell |
|
|||||
|
2020
Q3 | $922K | Buy |
|
|||||
|
2020
Q2 | $3.11M | Buy |
|
|||||
|
2020
Q1 | $1.65M | Sell |
|
|||||
|
2019
Q4 | $1.88M | Buy |
|
|||||
|
2019
Q3 | $352K | Buy |
|
|||||
|
2019
Q2 | $54K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $216K | Sell |
|
|||||
|
2017
Q4 | $592K | Sell |
|
|||||
|
2017
Q3 | $1.01M | Buy |
|